MedPath
FDA Approval

Terbutaline Sulfate

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
November 15, 2019
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Terbutaline(2.5 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

ANI Pharmaceuticals, Inc.

145588013

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Terbutaline Sulfate

Product Details

NDC Product Code
62559-721
Application Number
NDA017849
Marketing Category
NDA authorized generic (C73605)
Route of Administration
ORAL
Effective Date
October 16, 2018
Code: 576PU70Y8EClass: ACTIBQuantity: 2.5 mg in 1 1
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
POVIDONE K30Inactive
Code: U725QWY32XClass: IACT

Terbutaline Sulfate

Product Details

NDC Product Code
62559-722
Application Number
NDA017849
Marketing Category
NDA authorized generic (C73605)
Route of Administration
ORAL
Effective Date
October 16, 2018
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
Code: 576PU70Y8EClass: ACTIBQuantity: 5 mg in 1 1
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
POVIDONE K30Inactive
Code: U725QWY32XClass: IACT
© Copyright 2025. All Rights Reserved by MedPath